LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: De novo

    Roy, Anindya / Shi, Lei / Chang, Ashley / Dong, Xianchi / Fernandez, Andres / Kraft, John C / Li, Jing / Le, Viet Q / Winegar, Rebecca Viazzo / Cherf, Gerald Maxwell / Slocum, Dean / Daniel Poulson, P / Casper, Garrett E / Vallecillo-Zúniga, Mary L / Valdoz, Jonard Corpuz / Miranda, Marcos C / Bai, Hua / Kipnis, Yakov / Olshefsky, Audrey /
    Priya, Tanu / Carter, Lauren / Ravichandran, Rashmi / Chow, Cameron M / Johnson, Max R / Cheng, Suna / Smith, McKaela / Overed-Sayer, Catherine / Finch, Donna K / Lowe, David / Bera, Asim K / Matute-Bello, Gustavo / Birkland, Timothy P / DiMaio, Frank / Raghu, Ganesh / Cochran, Jennifer R / Stewart, Lance J / Campbell, Melody G / Van Ry, Pam M / Springer, Timothy / Baker, David

    bioRxiv : the preprint server for biology

    2023  

    Abstract: The RGD (Arg-Gly-Asp)-binding integrins αvβ6 and αvβ8 are clinically validated cancer and fibrosis targets of considerable therapeutic importance. Compounds that can discriminate between the two closely related integrin proteins and other RGD integrins, ... ...

    Abstract The RGD (Arg-Gly-Asp)-binding integrins αvβ6 and αvβ8 are clinically validated cancer and fibrosis targets of considerable therapeutic importance. Compounds that can discriminate between the two closely related integrin proteins and other RGD integrins, stabilize specific conformational states, and have sufficient stability enabling tissue restricted administration could have considerable therapeutic utility. Existing small molecules and antibody inhibitors do not have all of these properties, and hence there is a need for new approaches. Here we describe a method for computationally designing hyperstable RGD-containing miniproteins that are highly selective for a single RGD integrin heterodimer and conformational state, and use this strategy to design inhibitors of αvβ6 and αvβ8 with high selectivity. The αvβ6 and αvβ8 inhibitors have picomolar affinities for their targets, and >1000-fold selectivity over other RGD integrins. CryoEM structures are within 0.6-0.7Å root-mean-square deviation (RMSD) to the computational design models; the designed αvβ6 inhibitor and native ligand stabilize the open conformation in contrast to the therapeutic anti-αvβ6 antibody BG00011 that stabilizes the bent-closed conformation and caused on-target toxicity in patients with lung fibrosis, and the αvβ8 inhibitor maintains the constitutively fixed extended-closed αvβ8 conformation. In a mouse model of bleomycin-induced lung fibrosis, the αvβ6 inhibitor potently reduced fibrotic burden and improved overall lung mechanics when delivered via oropharyngeal administration mimicking inhalation, demonstrating the therapeutic potential of
    Language English
    Publishing date 2023-06-12
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.06.12.544624
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8.

    Roy, Anindya / Shi, Lei / Chang, Ashley / Dong, Xianchi / Fernandez, Andres / Kraft, John C / Li, Jing / Le, Viet Q / Winegar, Rebecca Viazzo / Cherf, Gerald Maxwell / Slocum, Dean / Poulson, P Daniel / Casper, Garrett E / Vallecillo-Zúniga, Mary L / Valdoz, Jonard Corpuz / Miranda, Marcos C / Bai, Hua / Kipnis, Yakov / Olshefsky, Audrey /
    Priya, Tanu / Carter, Lauren / Ravichandran, Rashmi / Chow, Cameron M / Johnson, Max R / Cheng, Suna / Smith, McKaela / Overed-Sayer, Catherine / Finch, Donna K / Lowe, David / Bera, Asim K / Matute-Bello, Gustavo / Birkland, Timothy P / DiMaio, Frank / Raghu, Ganesh / Cochran, Jennifer R / Stewart, Lance J / Campbell, Melody G / Van Ry, Pam M / Springer, Timothy / Baker, David

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 5660

    Abstract: The RGD (Arg-Gly-Asp)-binding integrins αvβ6 and αvβ8 are clinically validated cancer and fibrosis targets of considerable therapeutic importance. Compounds that can discriminate between homologous αvβ6 and αvβ8 and other RGD integrins, stabilize ... ...

    Abstract The RGD (Arg-Gly-Asp)-binding integrins αvβ6 and αvβ8 are clinically validated cancer and fibrosis targets of considerable therapeutic importance. Compounds that can discriminate between homologous αvβ6 and αvβ8 and other RGD integrins, stabilize specific conformational states, and have high thermal stability could have considerable therapeutic utility. Existing small molecule and antibody inhibitors do not have all these properties, and hence new approaches are needed. Here we describe a generalized method for computationally designing RGD-containing miniproteins selective for a single RGD integrin heterodimer and conformational state. We design hyperstable, selective αvβ6 and αvβ8 inhibitors that bind with picomolar affinity. CryoEM structures of the designed inhibitor-integrin complexes are very close to the computational design models, and show that the inhibitors stabilize specific conformational states of the αvβ6 and the αvβ8 integrins. In a lung fibrosis mouse model, the αvβ6 inhibitor potently reduced fibrotic burden and improved overall lung mechanics, demonstrating the therapeutic potential of de novo designed integrin binding proteins with high selectivity.
    MeSH term(s) Animals ; Mice ; Integrins ; Cell Membrane ; Cryoelectron Microscopy ; Disease Models, Animal ; Pulmonary Fibrosis
    Chemical Substances Integrins
    Language English
    Publishing date 2023-09-13
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-41272-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top